Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients

Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19.

Author

V V Kakkar¹

Affiliation

¹ Thrombosis Research Institute, London, UK.

PMID: 9399405

No abstract available

Publication types

Review

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / economics
Anticoagulants / therapeutic use*
Cost-Benefit Analysis
Fibrinolytic Agents / adverse effects
Fibrinolytic Agents / economics
Fibrinolytic Agents / therapeutic use*
Heparin, Low-Molecular-Weight / adverse effects
Heparin, Low-Molecular-Weight / economics
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Postoperative Complications / economics
Postoperative Complications / physiopathology
Postoperative Complications / prevention & control*
Pulmonary Embolism / economics
Pulmonary Embolism / physiopathology
Pulmonary Embolism / prevention & control*
Risk Factors
Thrombophlebitis / economics
Thrombophlebitis / physiopathology
Thrombophlebitis / prevention & control*

Substances

Anticoagulants
Fibrinolytic Agents
Heparin, Low-Molecular-Weight